Matrix Advanced Solutions
Peptide Dosing Guide
GH Secretagogue
Ipamorelin
Stimulates pituitary GH release via ghrelin/GHS-R1a receptor — cleaner profile with no hunger or cortisol spikes.
VIAL IMAGE NEEDED
What It Is
A growth hormone secretagogue that stimulates your body to release more of its own GH. One of the cleaner peptides — doesn't spike hunger or cortisol like GHRP-6. Used for recovery, fat loss support, and anti-aging.
Mechanism of Action
Ipamorelin acts on the ghrelin/GHS-R1a receptor in the pituitary gland, stimulating the release of endogenous growth hormone. Unlike older GH secretagogues such as GHRP-6, it has a cleaner profile — it does not significantly increase hunger, cortisol, or prolactin levels, making it one of the most selective GHS peptides available.
Key Benefits
Improved sleep quality
Enhanced recovery
Subtle fat loss support
IGF-1 elevation
Anti-aging support
Dosing Protocol
| Tier |
Dose |
Frequency |
Notes |
| Starting |
200 mcg |
Daily (bedtime) |
Begin here to assess tolerance |
| Moderate |
300 mcg |
Daily |
Standard protocol dose |
| High |
500 mcg |
Daily |
Advanced — monitor IGF-1 |
Cycle Length: 8–12 weeks
Timing: Before bed or fasted
Route: Subcutaneous injection
Must be fasted — insulin suppresses GH release. Do not inject after eating.
Administration & Reconstitution
- Reconstitution: BAC water, 1–2 mL per vial
- Needle: 31G insulin syringe, subcutaneous
- Storage: Refrigerate after reconstitution
Recommended Stacks
- CJC-1295 DAC — stronger, sustained GH pulse (GHRH + GHS synergy)
- Magnesium + electrolytes — supports sleep and recovery
- High protein — minimum bodyweight x 1 g/day
How To Know It's Working
- Deeper, more restorative sleep
- Faster recovery between training sessions
- Subtle fat loss over time
- IGF-1 rises on bloodwork (primary confirmation)
Protocol Notes & Common Mistakes
- Do not expect HGH-level results — Ipamorelin amplifies your own GH, it does not replace it
- Do not run cycles too short — benefits build over weeks
- Do not skip diet and protein basics — the peptide supports, it does not override fundamentals
- Do not overdose expecting faster fat loss — higher doses increase side effects without proportional benefit
Safety & Side Effects
Possible side effects:
- Mild water retention or bloating
- Injection site redness
- Possible headaches at high doses
Ipamorelin has a clean side-effect profile compared to older GHS peptides (GHRP-2, GHRP-6). However, long-term data remains limited.
Monitoring: IGF-1 at 6 weeks is the primary safety and efficacy marker. If IGF-1 is elevated above range, reduce dose or pause the protocol.